149 related articles for article (PubMed ID: 25826890)
1. [Research progress of effects of strontium ranelate on osteoarthritis].
Wang Y; Dai M; Tian F; Zhang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1479-83. PubMed ID: 25826890
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium.
Pelletier JP; Kapoor M; Fahmi H; Lajeunesse D; Blesius A; Maillet J; Martel-Pelletier J
Ann Rheum Dis; 2013 Feb; 72(2):250-7. PubMed ID: 23065732
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis.
Chu JG; Dai MW; Wang Y; Tian FM; Song HP; Xiao YP; Shao LT; Zhang YZ; Zhang L
BMC Musculoskelet Disord; 2017 Feb; 18(1):78. PubMed ID: 28187731
[TBL] [Abstract][Full Text] [Related]
5. [Research progress of protective effects of alendronate on articular cartilage in osteoarthritis].
He D; Yin M; Luo Y; Wei Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Oct; 26(10):1187-90. PubMed ID: 23167100
[TBL] [Abstract][Full Text] [Related]
6. What about strontium ranelate in osteoarthritis? Doubts and securities.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Mod Rheumatol; 2014 Nov; 24(6):881-4. PubMed ID: 24645726
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate, a promising disease modifying osteoarthritis drug.
Han W; Fan S; Bai X; Ding C
Expert Opin Investig Drugs; 2017 Mar; 26(3):375-380. PubMed ID: 28092725
[TBL] [Abstract][Full Text] [Related]
8. Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model.
Yu DG; Ding HF; Mao YQ; Liu M; Yu B; Zhao X; Wang XQ; Li Y; Liu GW; Nie SB; Liu S; Zhu ZA
Acta Pharmacol Sin; 2013 Mar; 34(3):393-402. PubMed ID: 23334238
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis.
Alexandersen P; Karsdal MA; Byrjalsen I; Christiansen C
Climacteric; 2011 Apr; 14(2):236-43. PubMed ID: 20726814
[TBL] [Abstract][Full Text] [Related]
10. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
Karsdal MA; Bay-Jensen AC; Lories RJ; Abramson S; Spector T; Pastoureau P; Christiansen C; Attur M; Henriksen K; Goldring SR; Kraus V
Ann Rheum Dis; 2014 Feb; 73(2):336-48. PubMed ID: 24285494
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review.
Rodrigues TA; Freire AO; Bonfim BF; Cartágenes MSS; Garcia JBS
Braz J Med Biol Res; 2018; 51(8):e7440. PubMed ID: 29924137
[TBL] [Abstract][Full Text] [Related]
14. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
[TBL] [Abstract][Full Text] [Related]
15. Effects of strontium ranelate on spinal osteoarthritis progression.
Bruyere O; Delferriere D; Roux C; Wark JD; Spector T; Devogelaer JP; Brixen K; Adami S; Fechtenbaum J; Kolta S; Reginster JY
Ann Rheum Dis; 2008 Mar; 67(3):335-9. PubMed ID: 17965119
[TBL] [Abstract][Full Text] [Related]
16. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
Siebelt M; Waarsing JH; Groen HC; Müller C; Koelewijn SJ; de Blois E; Verhaar JA; de Jong M; Weinans H
Bone; 2014 Sep; 66():163-70. PubMed ID: 24933343
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms of action of bisphosphonates and strontium ranelate].
Vengerovskiĭ AI; Khlusov IA; Nechaev KA
Eksp Klin Farmakol; 2014; 77(9):43-6. PubMed ID: 25365870
[TBL] [Abstract][Full Text] [Related]
18. Rationale for the potential use of calcitonin in osteoarthritis.
Manicourt DH; Devogelaer JP; Azria M; Silverman S
J Musculoskelet Neuronal Interact; 2005; 5(3):285-93. PubMed ID: 16172519
[TBL] [Abstract][Full Text] [Related]
19. Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.
Pemmer B; Hofstaetter JG; Meirer F; Smolek S; Wobrauschek P; Simon R; Fuchs RK; Allen MR; Condon KW; Reinwald S; Phipps RJ; Burr DB; Paschalis EP; Klaushofer K; Streli C; Roschger P
J Synchrotron Radiat; 2011 Nov; 18(Pt 6):835-41. PubMed ID: 21997907
[TBL] [Abstract][Full Text] [Related]
20. Impact of treatments for osteoporosis on cartilage biomarkers in humans.
Richette P; Roux C
Osteoporos Int; 2012 Dec; 23 Suppl 8():S877-80. PubMed ID: 23179570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
